Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-02

Clinical Trial Update: Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial evaluating the efficacy of chloroquine or hydroxychloroquine in treating COVID-19/COVID-19 Coronavirus Infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Tanta University | Conditions: COVID-19, Coronavirus Infection | Phase 2, Phase 3 | Status: COMPLETED